Series B - Parse Biosciences - 2022-02-15 - Crunchbase

Feb 15, 2022 · Parse Biosciences raised $41500000 on 2022-02-15 in Series B. Search Crunchbase. Start Free Trial . Chrome Extension ... Summary. Overview. Edit Overview …

CouponFollow Extension

$41500000
OFF

Series B - Parse Biosciences - 2022-02-15 - Crunchbase

6 days from now

Feb 15, 2022 · Parse Biosciences raised $41500000 on 2022-02-15 in Series B. Search Crunchbase. Start Free Trial . Chrome Extension ... Summary. Overview. Edit Overview …

crunchbase.com

$41
OFF

Parse Biosciences Raises $41.5M Series B Round To Scale Single …

6 days from now

Feb 15, 2022 · Parse Biosciences Launches Evercode Low Input Fixation for Cells and Nuclei. ... Parse Biosciences Raises $41.5M Series B Round to Scale Single-Cell Sequencing Products …

parsebiosciences.com

$41
OFF

Parse Biosciences Raises $41.5M Series B Round To Scale

6 days from now

Parse Biosciences Raises $41.5M Series B Round to Scale ... - BioSpace

biospace.com

$41
OFF

Parse Biosciences Raises $41.5M Series B Round To Scale Single …

6 days from now

Feb 15, 2022 · SEATTLE — Parse Biosciences, a company dedicated to providing scalable single-cell sequencing solutions, today announced $41.5M in Series B funding co-led by …

financialpost.com

$41
OFF

Parse Biosciences Raises $41.5M For Single-cell Sequencing Products

6 days from now

February 16, 2022-- Parse Biosciences has obtained $41.5 million in series B funding, bringing its total funding to date to over $50 million. Parse Biosciences is focused on providing scalable …

scienceboard.net

$41
OFF

Parse Biosciences Secures $41.5M Series B - Vcnewsdaily.com

6 days from now

2022-02-15 Tweet SEATTLE, WA, Parse Biosciences, a company dedicated to providing scalable single-cell sequencing solutions, today announced $41.5 million in Series B funding.

vcnewsdaily.com

$41
OFF

Parse Biosciences Closes $41.5M Series B Round - GenomeWeb

6 days from now

Feb 15, 2022 · NEW YORK – Single-cell genomics company Parse Biosciences said Tuesday it has closed a $41.5 million Series B financing round. The Seattle-based firm said it will use the …

genomeweb.com

$41
OFF

DEAL NOTE: Crowell Represents Marshall Wace In $41.5 Million …

6 days from now

San Francisco – February 16, 2022: Crowell & Moring represented Marshall Wace, a global alternative investment manager, in a $41.5 million Series B round of funding of Parse …

crowell.com

$41500000
OFF

Founder Lodge | Parse Biosciences Raises $41,500,000 At Series B …

6 days from now

Feb 15, 2022 · Parse Biosciences raises $41,500,000 at Series B on 2022-02-15 in Biotechnology Research, industry founded/co-founded by Alex Rosenberg. Daily News; Rounds; Investors; …

founderlodge.com

$41
OFF

Parse Biosciences Raises $41.5M Series B Round To Scale Single-cell ...

6 days from now

Feb 16, 2022 · Seattle--(ANTARA/Business Wire)- Parse Biosciences, a company dedicated to providing scalable single-cell sequencing solutions, today announced $41.5M in Series B …

antaranews.com

$41
OFF

Parse Biosciences Raises $41.5M Series B Round To Scale Single …

6 days from now

Feb 16, 2022 · Company to commercialize and create single-cell multi-omics products SEATTLE–(BUSINESS WIRE)–Feb. 15, 2022 Parse Biosciences, a company dedicated to …

thelasis.com

$7
OFF

With $7M Series A, Parse Biosciences Makes Gene ... - Crunchbase …

6 days from now

Jan 26, 2021 · Split Biosciences, a startup developing a single-cell sequencing kit that doesn’t require custom instrumentation, closed on $7 million in Series A funding and unveiled its new …

crunchbase.com

$50000000
OFF

Series C - Parse Biosciences - 2023-12-14 - Crunchbase

6 days from now

Dec 15, 2023 · Parse Biosciences raised $50000000 on 2023-12-14 in Series C. Search Crunchbase. Start Free Trial . Chrome Extension. Solutions. Products. Resources. Pricing. …

crunchbase.com

$71
OFF

Series B - Resolve BioSciences - 2022-10-24 - Crunchbase

6 days from now

Oct 24, 2022 · Business Wire — Resolve Biosciences Secures $71 Million Series B Financing to Accelerate Commercial Expansion to Meet Global Demand for Molecular Cartography™ …

crunchbase.com

FAQs about Series B - Parse Biosciences - 2022-02-15 - Crunchbase Coupon?

Does parse biosciences have a scalable single-cell sequencing solution?

SEATTLE-- (BUSINESS WIRE)-- Parse Biosciences, a company dedicated to providing scalable single-cell sequencing solutions, today announced $41.5M in Series B funding co-led by Marshall Wace and Janus Henderson Investors. ...

How much funding did parse Biosciences get?

Soleus Capital, Logos Capital and Bioeconomy Capital also participated in the round, bringing Parse Biosciences’ total funding to date to over $50M. “Understanding and thoroughly profiling cells at scale is fundamental to the future of groundbreaking discoveries in fields like oncology, immunology, and neuroscience” ...

What happened to parse Biosciences?

“Since our Series A close, Parse has experienced unprecedented growth,” said Charlie Roco, CTO and co-founder of Parse Biosciences. “We’re continuing to develop our platform based on the needs of our customers, who are using single-cell sequencing at scale in ways we’ve never seen before. ...

What is Parse Biosciences?

Parse Biosciences is a company that announced a partnership with Decode Science to provide its single-cell RNA-seq solution to the Australian and New Zealand markets (Passage). Under an agreement between the parties, Decode Science has been appointed as a distributor of Parse's product portfolio for Australia and New Zealand. ...

Is parse Biosciences a good RNA sequencing company?

The company is growing fast: Parse Biosciences launched its first products last year and on Tuesday announced $41.5 million in new funding. The Seattle-based company is an entry in the nascent field of single-cell RNA sequencing, where multiple methods have been developed and companies are jostling for long-term dominance. ...

Does parse biosciences have an edge?

Parse Biosciences has an edge because it does not rely on specialized equipment or devices, said Rosenberg, unlike market leader 10x Genomics and other companies. That keeps Parse Biosciences’ kits simple, and easy to use for scaling up to large numbers of cells. The company sells three kits with accompanying software. ...